Gaba and hepatocellular carcinoma

Molecular and Cellular Biochemistry

Volumn 207, Issue 1-2, 2000, Pages 105-108

  Minuk, G Y ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Cancer; GABA; Gamma aminobutyric acid; Hepatoma; Liver cancer; Liver disease; Polyamines

Indexed keywords

4 AMINOBUTYRIC ACID; POLYAMINE;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; HUMAN; LIVER CELL CARCINOMA; POLYAMINE METABOLISM; SIGNAL TRANSDUCTION;

EID: 0034093876     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007062802164     Document Type: Article

References (42)

1. London WT: Primary hepatocellular carcinoma - etiology, pathogenesis, and prevention. Hum Pathol 12: 1085-1097, 1981
2. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT: Hepatocellular carcinoma. Ann Intern Med 108: 390-401, 1988
3. Hobbs KEF, Dusheiko GM: Management of Hepatocellular carcinoma. J Hepatol 15: 281-283, 1992
4. Okuda K: Hepatocellular carcinoma: Recent progress. Hepatology 15: 948-963, 1992
5. Pegg AE, McCann PP: Polyamine metabolism and function. Am J Physiol 243: C212-C221, 1982
6. Luk GD: Essential role of polyamine metabolism in hepatic regeneration: inhibition of deoxyribonucleic acid and protein synthesis and tissue regeneration by difluoromethylornithine in the rat. Gastroenterology 90: 1261-1267, 1986
7. Russell DH, Snyder SH: Amine synthesis in regenerating rat liver: extremely rapid turnover of ornithine decarboxylase. Mol Pharmacol 5: 253-262, 1969
8. Minuk GY, Gauthier T, Benarroch A: Changes in serum and hepatic polyamine concentrations following 30%, 70% and 90% partial hepatectomy in rats. Hepatology 12: 542-546, 1990
9. Nishiguchi S, Kuroki T, Takeda T, Nakajima S, Shiomi S, Seki S, Matsui-Yuasa I, Otani S, Kobayashi K: Effects of putrescine on D-galactosamine-induced acute liver failure in rats. Hepatology 12: 348-353, 1990
10. Diehl AM, Abdo S, Braun N: Supplemental putrescine reverses ethanol-associated inhibition of liver regeneration. Hepatology 12: 633-637, 1990
11. Janne J, Alhonen L, Leinonen P: Polyamines: from molecular biology to clinical applications. Ann Med 23: 241-259, 1991
12. Haddox MK, Russell DH: Increased nuclear conjugated polyamines and transglutaminase during liver regeneration. Proc Natl Acad Sci USA 78: 1712-1716, 1981
13. Poso JH, Raina A: Polyamines in rapid growth and cancer. Biochim Biophys Acta 473: 241-293, 1978
14. Minuk GY, Kren BT, Xu R, Zhang XK, Burczynski FJ, Mulrooney NP, Fan G, Steer CJ: The effect of changes in hepatocyte membrne potential on immediate-early protooncogene expression following partial hepatectomy in rats. Hepatology 25: 1123-1127, 1997
15. Zhang XK, Gauthier T, Burczynski FJ, Wang GQ, Gong Y, Minuk GY: Changes in liver membrane potentials after partial hepatectomy in rats. Hepatology 23: 549-551, 1996
16. 3H] GABA binding to isolated rat hepatocytes. Am J Physiol 252: 642-647, 1987
17. A receptors. Biochem J 310: 1-9, 1995
18. Nelson MT, Blaustein MP: GABA efflux from synaptosomes: effects of membrane potential and external GABA and cations. J Membrane Biol 69: 213-223, 1982
19. Herbison AE: Estrogen regulation of GABA transmission in rat preoptic area. Brain Research Bulletin 44(4) 321-326, 1997
20. Minuk GY: Gamma-aminobutyric acid and the liver Dig Dis 11: 45-54, 1993
21. Minuk GY, Gauthier T: The effect of gamma aminobutyric acid (GABA) on hepatic regenerative activity following partial hepatectomy in rats. Gastroenterology 104: 217-221, 1993
22. Zhang XK, Gauthier T, Burczynski FJ, Wang GQ, Gong Y, Minuk GY: Ciprofloxacin prevents the inhibitor effects of acute ethanol exposure on hepatic regeneration in the rat. Hepatology 22: 1797-1800, 1995
23. Kaita KDE, Assy N, Gauthier T, Meyers AFA, Minuk GY: Beneficial effects of ciprofloxacin on survival and hepatic regenerative activity in a rat model of fulminant hepatic failure. Hepatology 27: 533-536, 1998
24. Zhang M, Song G, Minuk GY: Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E, and ciprofloxacin on cirrhosis in the rat. Gastroenterology 110: 1150-1155, 1996
25. Janne J, Poso H, Raina A: Polyamines in rapid growth and cancer. Biochim Biophys Acta 473: 241-293, 1978
26. Auvinen M, Paasinen A, Andersson LC, et al: Ornithine decarboxylase activity is critical for cell transformation. Nature 360: 355-358, 1992
27. Don S, Bachrach U: Polyamine metabolism in normal and in virus-transformed chick embryo fibroblasts. Cancer Res 35: 3618-3622, 1975
28. Tamori A, Nishiguchi S, Kuroki T, Seki S, Kobayashi K, Kinoshita H, Otani S: Relationship of ornithine decarboxylase activity and histological findings in human hepatocellular carcinoma. Hepatology 20: 1179-1186, 1994
29. Sunkara PS, Baylin SB, Luk GD: Inhibitors of polyamine biosynthesis: Cellular and in vivo effects on tumor proliferation. In: P.P. McCann, A.E. Pegg, A. Sjoerdsma (eds). Inhibition of Polyamine Metabolism: Biological Significance and Basis for New Therapies. Academic Press, San Diego, 1987, pp 2-36
30. Manni A, Badger B, Lynch J, Demers L: Selectivity of polyamine involvement in hormone action on normal and neoplastic target tissues of the rat. Breast Cancer Res Treat 17: 187-196, 1990
31. Kim I, Manni A, Lynch J, Demers L: Polyamine involvement in the secretion and action of TGF-α in hormone sensitive human breast cancer cells in culture. Breast Cancer Res Treat 18: 83-91, 1991
32. Holtta E, Sistonen L, Alitalo K: The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J Biol Chem 263: 4500-4507,1988
33. Boggust WA, Al-Nakib T: Promotion and suppression of tumour growth and cell proliferation by acetylputrescine and putrescine and their oxidation products acetyl-GABA and GABA. IRCS Med Sci 14: 174-175, 1986
34. Cerino A, De Amici M, Fussi FF, Ricotti GCBA: Carboxyethyl γ-aminobutyric acid, a polyamine derivative molecule with a growth effect on hybridomas. J Immunol Methods 77: 229-235, 1985
35. Tsutsumi I, Ido A, Nakao K, Hamasaki K, Kato Y, Ohtsuru A, Nakata K, Tamaoki T, Nagataki S: Reciprocal regulation of α-fegoprotein and albumin gene expression by butyrate in human hepatoma cells. Gastroenterology 107: 499-504, 1994
36. Leder A, Leder P: Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 5: 319-322, 1975
37. Langdon SP, Hawkes MM, Hay FG, Lawrie SS, Schiol DJ, Hilgers J, Leonard RCF, Smyth JF: Effect of sodium butyrate and other differentiation inducers on poorly differentiated human ovarian adenocarcinoma cell lines. Cancer Res 48: 6161-6165, 1988
38. McGovren JP, Williams MG, Tang AH, Vonvoigtland PF, Piercey MF, Einspahr FJ, Schreur PJ: Animal behavioral and neurochemical effects of the CNS toxic amino acid antitumor agent, acivicin. Res Commun Chem Pathol Pharmacol 63: 215-229, 1989
39. Marino AA, Iliev KG, Schwalke MA, Gonzalez E, Marler KC, Flanagan CA: Association between cell membrane potential and breast cancer. Tumor Biol 15: 82-89, 1994
40. 2 human hepatocellular carcinoma cell line. J Hepatol 32: 85-91, 2000
41. Shiina S, Tagawa K, Unuma T, Fujino H, Uta Y, Niwa Y, Hata Y, Komatsu Y, Shiratori Y, Terano A, Sugimoto T: Percutaneous ethanol injection therapy of hepatocellular carcinoma: Analysis of 77 patients. AJR 155: 1221-1226, 1990
42. Gong Y, Cui L, Zhang MN, Burczynski FJ, Minuk GY: Decreased GABAergic activity in human hepatocellular carcinoma. Hepatology 26: 131A, 1997